SCHEMBL19848878

SCHEMBL19848878

O=C1c2cccc(-n3c4ccccc4c4cccc(-c5ccc(C(F)(F)F)cc5C(F)(F)F)c43)c2C(=O)N1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GALR3 O60755 1/20 0.43
HTR4 Q13639 1/20 0.43
HSPA1A P0DMV8 1/20 0.39
PABPC1 P11940 1/20 0.39
ALDH1A1 P00352 5/20 0.38
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 4/20 0.38
HTT P42858 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
USP2 O75604 3/20 0.38
MAPT P10636 2/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
LMNA P02545 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.37
APOBEC3A P31941 1/20 0.37
RECQL P46063 1/20 0.37
CASP6 P55212 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19848872 0.95 GALR3 (0.45) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19843292 0.94 PDE6D (0.40) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19842893 0.94 CYP2C9 (0.38) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19843154 0.92 CYP2C9 (0.36) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19843322 0.91 NR1H2 (0.38) GALR3HTR4ALDH1A1HTTSMN1; SMN2
SCHEMBL19843148 0.91 GALR3 (0.36) GALR3HTR4ALDH1A1HTTSMN1; SMN2
SCHEMBL23476491 0.90 PDE6D (0.42) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19848943 0.90 GALR3 (0.42) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19842884 0.89 CYP2C9 (0.40) GALR3HTR4HSPA1APABPC1ALDH1A1
SCHEMBL19843205 0.88 EDNRB (0.35) GALR3HTR4ALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 US disclosed
EP-3494113-B1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-10-06 EP disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 US disclosed
EP-3279193-B1 COMPOUNDS COMPRISING A PHTHALIMIDE GROUP AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-05-08 EP disclosed
WO-2018024723-A1 PHTHALIMIDE AND CARBAZOLE OR ANALOGS THEREOF CONTAINING COMPOUNDS FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 WO disclosed
EP-3279193-A1 COMPOUNDS COMPRISING PHTHALIMIDE AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L GALR3 367/4885HTR4 475/4885HSPA1A 4232/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM GALR3 990/4885HTR4 2843/4885HSPA1A 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.